Related Experiment Video
Updated: Jul 19, 2026

Collection of Alfalfa Root Exudates to Study the Impact of Di(2-ethylhexyl) Phthalate on Metabolite Production
Published on: June 2, 2023
Phthalate esters in human milk: concentration variations over a 6-month postpartum time
Jiping Zhu1, Susan P Phillips, Yong-Lai Feng
1Chemistry Research Division, Health Canada AL: 0800C, EHC (Building 8), Tunney's Pasture, Ottawa, Ontario, Canada K1A 0L2. Jiping_Zhu@hc-sc.gc.ca
Phthalate esters, particularly Di(2-ethylhexyl) phthalate (DEHP), were detected in human milk. Levels fluctuated, suggesting multiple samples are needed to accurately assess infant exposure to these common chemicals.
Area of Science:
- Environmental Health
- Toxicology
- Human Lactation Studies
Background:
- Phthalate esters are widely used plasticizers with potential endocrine-disrupting properties.
- Human milk is a critical source of nutrition for infants, but can also be a route of exposure to environmental contaminants.
- Understanding phthalate levels in human milk is crucial for assessing infant health risks.
Purpose of the Study:
- To quantify phthalate ester levels in human milk samples.
- To investigate the fluctuation of phthalate concentrations over a 6-month postpartum period.
- To estimate the daily intake of phthalates by breast-fed infants.
Main Methods:
- Analysis of 86 human milk samples from 21 mothers over 6 months postpartum.
- Quantification of phthalate esters using gas chromatography-mass spectrometry (GC-MS).
- Calculation of estimated daily intake for infants based on milk consumption and phthalate levels.
Main Results:
- Di(2-ethylhexyl) phthalate (DEHP) was the most abundant phthalate, with a mean of 222 ng/g.
- Dibutyl phthalate (DBP) and Diethyl phthalate (DEP) were found at lower concentrations.
- Phthalate levels showed fluctuations over the 6-month period, with weak correlations to milk lipid content.
Conclusions:
- Human milk contains detectable levels of phthalate esters, with DEHP being predominant.
- Fluctuating levels necessitate multiple sample collections for accurate exposure assessment.
- Breast-fed infants may be exposed to significant levels of DEHP, warranting further health risk evaluation.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Development of Human Microbiota

